Northstrive Biosciences Inc., a Subsidiary of PMGC Holdings Inc., Announces Successful Submission of Pre-IND Meeting Request to FDA for EL-22, a Potential Breakthrough Obesity Therapy Targeting Fat Lo
February 18, 2025 | by ltcinsuranceshopper
Northstrive Biosciences Inc., a Subsidiary of PMGC Holdings Inc., Announces Successful Submission of Pre-IND Meeting Request to FDA for EL-22, a Potential Breakthrough Obesity Therapy Targeting Fat Lo
Source link
RELATED POSTS
View all
France and allies discuss holding informal Ukraine summit
February 15, 2025 | by ltcinsuranceshopper
Europe consigned to kids’ table in Ukraine peace talks, says defence CEO
February 18, 2025 | by ltcinsuranceshopper
AI startup Safe Superintelligence leases Tel Aviv offices
February 21, 2025 | by ltcinsuranceshopper
Trending topics include news, politics, sports, entertainment, music, tech, celebrities, and food covering major events, innovations, and viral moments.
Useful Links
Subscribe Now
Don’t miss our future updates! Get Subscribed Today!